Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo
- PMID: 20008287
- DOI: 10.4049/jimmunol.0900726
Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo
Abstract
Nucleotide oligomerization binding domain (Nod)-like receptors are critical cytosolic sensors for the recognition of bacterial peptidoglycan. However, their role in the induction of dendritic cell (DC)-mediated cross-priming remains unclear. In this study, we demonstrate that injecting ligands for Nod1 and Nod2 along with Ag into wild-type mice significantly enhanced the cross-priming of Ag-specific CD8+ T cells by CD8alpha+ DCs, as assessed from the expansion of IFN-gamma+ CD8+ T cells, CTL activity against Ag-pulsed targets, and the rejection of transplanted tumors expressing the cognate Ag. The enhancement of CD8alpha+ DC-mediated cross-priming was likely due to the upregulation of Ag cross-presentation and of costimulatory molecules. Our findings collectively indicate that Nod1/2 signaling is critical for the optimal induction of DC cross-priming in vivo, which may offer an alternative therapeutic pathway in cancer and hosts refractory to TLR signals or paralyzed by viral evasion strategy.
Similar articles
-
Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.J Immunol. 2010 Nov 15;185(10):6013-22. doi: 10.4049/jimmunol.1002129. Epub 2010 Oct 18. J Immunol. 2010. PMID: 20956347
-
Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.J Immunol. 2011 May 1;186(9):5142-50. doi: 10.4049/jimmunol.1004163. Epub 2011 Mar 25. J Immunol. 2011. PMID: 21441457
-
CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].J Immunol. 2011 Feb 1;186(3):1503-11. doi: 10.4049/jimmunol.1001022. Epub 2010 Dec 27. J Immunol. 2011. PMID: 21187449
-
Nod1 and Nod2 in innate immunity and human inflammatory disorders.Biochem Soc Trans. 2007 Dec;35(Pt 6):1479-84. doi: 10.1042/BST0351479. Biochem Soc Trans. 2007. PMID: 18031249 Review.
-
The intracellular location, mechanisms and outcomes of NOD1 signaling.Cytokine. 2015 Aug;74(2):207-12. doi: 10.1016/j.cyto.2015.02.018. Epub 2015 Mar 19. Cytokine. 2015. PMID: 25801093 Review.
Cited by
-
Presentation of phagocytosed antigens by MHC class I and II.Traffic. 2013 Feb;14(2):135-52. doi: 10.1111/tra.12026. Epub 2012 Nov 29. Traffic. 2013. PMID: 23127154 Free PMC article. Review.
-
Topical N-phosphonacetyl-l-aspartate is a dual action candidate for treating non-melanoma skin cancer.Exp Dermatol. 2023 Sep;32(9):1485-1497. doi: 10.1111/exd.14853. Epub 2023 Jun 13. Exp Dermatol. 2023. PMID: 37309615 Free PMC article.
-
Multifaceted roles and regulation of nucleotide-binding oligomerization domain containing proteins.Front Immunol. 2023 Oct 5;14:1242659. doi: 10.3389/fimmu.2023.1242659. eCollection 2023. Front Immunol. 2023. PMID: 37869013 Free PMC article. Review.
-
Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure.J Gen Virol. 2016 Apr;97(4):825-838. doi: 10.1099/jgv.0.000401. Epub 2016 Jan 13. J Gen Virol. 2016. PMID: 26763980 Free PMC article. Review.
-
Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer Cells.Front Pharmacol. 2022 Jul 22;13:920928. doi: 10.3389/fphar.2022.920928. eCollection 2022. Front Pharmacol. 2022. PMID: 35935855 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials